Serum Magnesium after Kidney Transplantation: A Systematic Review - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Nutrients Year : 2018

Serum Magnesium after Kidney Transplantation: A Systematic Review


Magnesium (Mg) status has recently drawn close attention in chronic kidney disease and in kidney transplant recipients. This review aims to evaluate the body of evidence linking hypomagnesemia to clinical consequences in these specific populations. After a brief summary of the main mechanisms involved in Mg regulation and of Mg status in end-stage renal disease, the review focuses on the relationship between hypomagnesemia and cardiovascular risk in kidney transplant recipients. A body of evidence in recent studies points to a negative impact of hypomagnesemia on post-transplant diabetes mellitus (PTDM) and cardiovascular risk, which currently represent the main threat for morbidity and mortality in kidney transplantation. Deleterious biological mechanisms induced by hypomagnesemia are also discussed. While data analysis enables us to conclude that hypomagnesemia is linked to the development of PTDM, studies prospectively evaluating the impact of hypomagnesemia correction after kidney transplantation are still lacking and needed.
Fichier principal
Vignette du fichier
nutrients-10-00729_2018Eq7.pdf (882.43 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

inserm-01815356 , version 1 (14-06-2018)



Anne-Sophie Garnier, Agnès Duveau, Martin Planchais, Jean-François Subra, Johnny Sayegh, et al.. Serum Magnesium after Kidney Transplantation: A Systematic Review. Nutrients, 2018, 10 (6), pp.E729. ⟨10.3390/nu10060729⟩. ⟨inserm-01815356⟩
62 View
83 Download



Gmail Facebook Twitter LinkedIn More